Previous studies revealed that copper (Cu)-induced regression of cardiomyocyte hypertrophy is associated with enhanced activity in the vascular endothelial growth factor receptor-1 (VEGFR-1) signaling pathway. The mechanism by which Cu enhances the activity of VEGFR-1 pathway remains to be defined. The present study was undertaken to test the hypothesis that Cu enhances the VEGFR-1 signaling pathway via suppression of the VEGFR-2 signaling pathway. Primary cultures of neonatal rat cardiomyocytes were exposed to phenylephrine (PE) at a final concentration of 100 µM in cultures for 48 h to induce cell hypertrophy. The hypertrophic cardiomyocytes were exposed to copper sulfate at a final concentration of 5 µM Cu in cultures for 24 h. Western blot analysis showed that PE increased the protein levels of both VEGFR-1 and VEGFR-2. Cu supplementation significantly reduced the increase in VEGFR-2, but had no effect on the elevation of VEGFR-1. Real-time polymerase chain reaction analysis found no difference in the mRNA levels between the VEGFR-1 and VEGFR-2 under the conditions defined above. This study thus demonstrated that Cu selectively suppressed PE-elevated VEGFR-2 levels likely via post-translational regulation, leading to the VEGFR-1 signaling pathway becoming dominant and thereby regressing cardiomyocyte hypertrophy.
ShyuKGLiouJYWangBWFangWJChangH. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart. J Biomed Sci2005; 12: 409–20.
2.
ShimojoNJesminSZaediSOtsukiTMaedaSYamaguchiNAonumaKHattoriYMiyauchiT. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol2007; 293: H474–81.
3.
SanoMMinaminoTTokoHMiyauchiHOrimoMQinYAkazawaHTatenoKKayamaYHaradaMShimizuIAsaharaTHamadaHTomitaSMolkentinJDZouYKomuroI. P53-induced inhibition of HIF-1 causes cardiac dysfunction during pressure overload. Nature2007; 446: 444–8.
4.
JiangYReynoldsCXiaoCFengWZhouZRodriguezWTyagiSCEatonJWSaariJTKangYJ. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med2007; 204: 657–66.
5.
ZhouYJiangYKangYJ. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol2008; 45: 106–17.
6.
ZhouYBourcyKKangYJ. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc Res2009; 84: 54–63.
7.
TakahashiTUenoHShibuyaM. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene1999; 18: 2221–30.
8.
KrollJWaltenbergerJ. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem1997; 272: 32521–7.
9.
SekoYTakahashiNTobeKUekiKKadowakiTYazakiY. Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes. J Cell Physiol1998; 175: 239–46.
10.
IzumiyaYShiojimaISatoKSawyerDBColucciWSWalshK. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension2006; 47: 887–93.
11.
ClerkASugdenPH. Activation of protein kinase cascades in the heart by hypertrophic G protein coupled receptor agonists. Am J Cardiol1999; 83: 64H–9H.
12.
DeBoschBTreskovILupuTSWeinheimerCKovacsACourtoisMMuslinAJ. Akt1 is required for physiological cardiac growth. Circulation2006; 113: 2097–104.
13.
BuenoOFDe WindtLJTymitzKMWittSAKimballTRKlevitskyRHewettTEJonesSPLeferDJPengCFKitsisRNMolkentinJD. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J2000; 19: 6341–50.
14.
FiedlerBLohmannSMSmolenskiALinnemullerSPieskeBSchroderFMolkentinJDDrexlerHWollertKC. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci2002; 99: 11363–8.
15.
WollertKCFiedlerBGambaryanSSmolenskiAHeinekeJButtETrautweinCLohmannSMDrexlerH. Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension2002; 39: 87–92.
16.
TakimotoEChampionHCLiMBelardiDRenSRodriguezERBedjaDGabrielsonKLWangYKassDA. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med2005; 11: 214–22.
17.
HouJKangYJ. Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets. Pharmacol Ther2012; 135: 337–54.
18.
HoffmannPRichardsDHeinroth-HoffmannIMathiasPWeyHToraasonM. Arachidonic acid disrupts calcium dynamics in neonatal rat cardiac myocytes. Cardiovasc Res1995; 30: 889–98.
19.
SiddiquiRAShaikhSRKovacsRStillwellWZalogaG. Inhibition of phenylephrine-induced cardiac hypertrophy by docosahexaenoic acid. J Cell Biochem2004; 92: 1141–59.
20.
BarronMGaoMLoughJ. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn2000; 218: 383–93.
21.
ZuoXDongDYSunMXieHQKangYJ. Homocysteine restricts copper availability leading to suppression of cytochrome c oxidase activity in phenylephrine-treated cardiomyocytes. PLoS One2013; 8: e67549–e67549.
22.
DongDYWangBYinWDingXQYuJJKangYJ. Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury. PLoS One2013; 8: e76209–e76209.
23.
LuZHunterT. Degradation of activated protein kinases by ubiquitination. Annu Rev Biochem2009; 78: 435–75.
24.
KobayashiSSawanoANojimaYShibuyaMMaruY. The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1). FASEB J2004; 18: 929–31.
25.
SinghAJMeyerRDBandHRahimiN. The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol Biol Cell2005; 16: 2106–18.
26.
MeyerRDSrinivasanSSinghAJMahoneyJEGharahassanlouKRRahimiN. PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. Mol Cell Biol2011; 31: 2010–25.
27.
SuzukiYNakabayashiYNakataKReedJCTakahashiR. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and -7 in distinct modes. J Biol Chem2000; 276: 27058–63.
28.
KaurSWangFVenkatramanMArsuraM. X-linked Inhibitor of Apoptosis (XIAP) Inhibits c-Jun N-terminal Kinase 1 (JNK1) activation by Transforming Growth Factor β1 (TGF-β1) through ubiquitin-mediated proteosomal degradation of the TGF-β1-activated Kinase 1 (TAK1). J Biol Chem2005; 280: 38599–608.
29.
BradyGFGalbánSLiuXBasrurVGitlinJDElenitoba-JohnsonKSWilsonTEDuckettCS. Regulation of the copper chaperone CCS by XIAP-mediated ubiquitination. Mol Cell Biol2010; 30: 1923–36.
30.
AirdKMGhanayemRBPeplinskiSLyerlyHKDeviGR. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Mol Cancer Ther2010; 9: 1432–42.
